U.S. markets closed

'We’ve completed the engineering on the medicine': Distributed Bio CEO on coronavirus cure

Distributed Bio CEO Jacob Glanville is actively working on a treatment for COVID-19. He joins Yahoo Finance’s On The Move panel to discuss how the antibodies their team acquired can be effective against the virus.